中文     English
Meihua Group (600873) will acquire 51% equity of Dalian Hanxin Shengwu with 336,600,000RMB (US $56.1million)

 

Meihua Group intends to sign an agreement with Liaoning Aimei Shengwu. Under this agreement, Liaoning Aimei Shengwu shall sell 51% of its equity of Dalian Hanxin Shengwu to Meihua Group. Dalian Hanxin Shengwu focuses on developing, manufacturing, and marketing vaccines, pilsl, small capacity injections, and freeze-dried powder injections

 

For more information, please contact us at david.chen@bfcgroup.biz